Correction: Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management [0.03%]
纠正：共识声明：关于促进行分化型甲状腺癌管理的行动标志物检测的建议
Ozgur Mete,Andrée Boucher,Kasmintan A Schrader et al.
Ozgur Mete et al.
Published Erratum
Endocrine pathology. 2024 Dec;35(4):309-310. DOI:10.1007/s12022-024-09843-y 2024
Clinicopathologic and Molecular Analysis of 15 Pediatric and Young Adult Patients with High-Grade Non-anaplastic Thyroid Carcinoma [0.03%]
15例青少年和年轻成人高分化非未分化甲状腺癌患者的临床病理及分子特征分析
Rumeal D Whaley,Sounak Gupta,Matthew C Manninen et al.
Rumeal D Whaley et al.
High-grade follicular cell-derived non-anaplastic thyroid carcinomas are uncommon and typically diagnosed in the sixth to seventh decade of life. These tumors are rare in the pediatric (≤ 18 years old) and young adult (19-21 years old) pop...
The Potential Utility of RAS Q61R Immunohistochemistry as a Screening Tool in Pre-operative Fine Needle Aspirates of Medullary Thyroid Carcinoma [0.03%]
术前细针抽吸物中降钙素阳性甲状腺结节原发性髓样癌的RAS Q61R免疫组织化学筛查价值评估
Brea Deyette,Daniel J Lubin,Aswathy M Cheriyan et al.
Brea Deyette et al.
Medullary thyroid carcinoma (MTC) can either be sporadic, often via mutually exclusive RET or RAS alterations, or inherited via a RET germline alteration. Germline testing is recommended for all patients diagnosed with MTC. RAS p.Q61R immun...
Clinicopathological Features of Epstein-Barr Virus-Positive Neuroendocrine Carcinoma: Analysis of Twenty-Two Cases [0.03%]
埃伯斯坦-巴尔病毒阳性神经内分泌癌的临床病理特征（22例分析）
Xiao-Ying Zhang,Jia Fu,Mei-Ling Chen et al.
Xiao-Ying Zhang et al.
Epstein-Barr Virus (EBV)-positive neuroendocrine carcinoma (NEC) is a rare neoplasm with limited histopathological and therapeutic data. This report presents 22 cases of EBV-positive NEC, analyzing age distribution, morphology, and immunoph...
Cauda Equina Neuroendocrine Tumors with Ganglioneuromatous Elements are Best Classified as Composite Gangliocytoma/Neuroma and Neuroendocrine Tumor (COGNET) [0.03%]
马尾神经内分泌肿瘤伴神经节神经瘤样成分最好归类为复合型 gangliocytoma/神经鞘瘤和神经内分泌肿瘤（COGNET）
Fatih Mert Dogukan,Ozgur Mete
Fatih Mert Dogukan
Consensus Statement: Recommendations on Actionable Biomarker Testing for Thyroid Cancer Management [0.03%]
共识声明：关于指导性生物标志物检测在甲状腺癌治疗中的推荐建议
Ozgur Mete,Andrée Boucher,Kasmintan A Schrader et al.
Ozgur Mete et al.
Thyroid cancer management is rapidly changing. The identification of actionable biomarkers through both germline and somatic testing are now an integral part of directing patient management. However, deficiencies and disparities within exis...
Practice Guideline
Endocrine pathology. 2024 Dec;35(4):293-308. DOI:10.1007/s12022-024-09836-x 2024
Multilineage Pituitary Neuroendocrine Tumors Expressing TPIT and SF1: A Clinicopathological Series of Six Tumors [0.03%]
六例TPIT和SF1阳性垂体神经内分泌肿瘤的临床病理系列研究报告
Sylvia L Asa,Gregg H Faiman,Amr Mohamed et al.
Sylvia L Asa et al.
Tumors of adenohypophysial hormone-secreting cells, now classified as pituitary neuroendocrine tumors (PitNETs), have been subclassified based on cell differentiation. Normal adenohypophysial cells have three lineages of differentiation dri...
Effective Preparation of FFPE Tissue Samples for Preserving Appropriate Nucleic Acid Quality for Genomic Analysis in Thyroid Carcinoma [0.03%]
甲状腺癌基因组分析保存适当核酸质量的有效福尔马林固定石蜡包埋组织样本制备方法
Yoichiro Okubo,Nagisa Toyama,Rika Kasajima et al.
Yoichiro Okubo et al.
Formalin-fixed paraffin-embedded (FFPE) tissue samples are important for genomic analysis of thyroid carcinomas, particularly for various molecularly targeted therapies. Therefore, this study developed and validated a technique for preparin...
Progression of Low-Grade Neuroendocrine Tumors (NET) to High-Grade Neoplasms Harboring the NEC-Like Co-alteration of RB1 and TP53 [0.03%]
低级别神经内分泌肿瘤(LNETs)演变为高级别类NEC肿瘤的RB1和TP53共改变模式
Nancy M Joseph,Sarah E Umetsu,Grace E Kim et al.
Nancy M Joseph et al.
High-grade or grade 3 epithelial neuroendocrine neoplasms (G3 NEN) are now divided into grade 3 well-differentiated neuroendocrine tumor (G3 NET) and neuroendocrine carcinoma (NEC), both defined by Ki-67 > 20% and/or > 20 mitoses per 2 mm2....